Concepedia

Di Jing

DJ

Statistics

Publications

23

Citations

1.4K

H-Index

17

Active since

2014

Affiliations

Central South University(Current)

Xiangya Hospital Central South University

University of California, Davis

Chinese Academy of Medical Sciences & Peking Union Medical College

Peking Union Medical College Hospital

Di Jing is an author at Central South University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2014–2023

23

Publications

23

Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo

Lu Zhang, Di Jing, Nian Jiang et al. · Nature Nanotechnology · 2020 · 266 citations · Full text

, , +16

Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion

Nian Jiang, Bowen Xie, Wenwu Xiao et al. · Nature Communications · 2022 · 245 citations · Full text

, , +17

Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment

Xiangdong Xue, Yee Huang, Ruonan Bo et al. · Nature Communications · 2018 · 197 citations · Full text

, , +17

Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells

Demet Candas-Green, Bowen Xie, Jie Huang et al. · Nature Communications · 2020 · 147 citations · Full text

, , +17

Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer

Lu Zhang, Di Jing, Lei Wang et al. · Nano Letters · 2018 · 68 citations

, , +17

1–5 of 23